Which angiosarcoma subtypes may benefit from immunotherapy?
van Ravensteijn, Stefan G, Versleijen-Jonkers, Yvonne MH, Hillebrandt-Roeffen, Melissa HS, Weidema, Marije E, Nederkoorn, Maikel JL, Gorris, Mark AJ, Verrijp, Kiek, Kroeze, Leonie I., de Bitter, Tessa, de Voer, Richarda M, Flucke, Uta E, Desar, Ingrid
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article